Immunologic Landscape News Today

The University of Iowa Health Care has joined a new Phase 2 clinical trial that will test booster vaccines in various combinations to determine which provide the best immune response against existing and emerging COVID-19 variants.

The University of Iowa Health Care has joined a new Phase 2 clinical trial that will test booster vaccines in various combinations to determine which provide the best immune response against existing and emerging COVID-19 variants.

Next steps may include variant-specific vaccines

The University of California San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot. 

UC San Diego joined a Phase II clinical trial to evaluate additional COVID-19 booster shots to see if different vaccine regimens can broaden immune responses in adults, it was announced Wednesday.

Adults have received FDA-authorized primary COVID-19 vaccination series and booster shot and are in generally good health may be eligible.

A Phase 2 clinical trial evaluating various additional COVID-19 booster shots has begun enrolling adult participants in the United States. The trial aims

A Phase 2 clinical trial evaluating various additional COVID-19 booster shots has begun enrolling adult participants in the United States.